Szostakowska-Rodzos, M.; Grzybowska, E.A.; Mysliwy, I.; Zub, R.; Jagiello-Gruszfeld, A.; Rubach, M.; Konieczna, A.; Fabisiewicz, A.
The Combined Assessment of CTC and ESR1 Status in Liquid Biopsy Samples Enhances the Clinical Value of Prediction in Metastatic Breast Cancer. Int. J. Mol. Sci. 2025, 26, 2038.
https://doi.org/10.3390/ijms26052038
AMA Style
Szostakowska-Rodzos M, Grzybowska EA, Mysliwy I, Zub R, Jagiello-Gruszfeld A, Rubach M, Konieczna A, Fabisiewicz A.
The Combined Assessment of CTC and ESR1 Status in Liquid Biopsy Samples Enhances the Clinical Value of Prediction in Metastatic Breast Cancer. International Journal of Molecular Sciences. 2025; 26(5):2038.
https://doi.org/10.3390/ijms26052038
Chicago/Turabian Style
Szostakowska-Rodzos, Malgorzata, Ewa A. Grzybowska, Izabella Mysliwy, Renata Zub, Agnieszka Jagiello-Gruszfeld, Maryna Rubach, Aleksandra Konieczna, and Anna Fabisiewicz.
2025. "The Combined Assessment of CTC and ESR1 Status in Liquid Biopsy Samples Enhances the Clinical Value of Prediction in Metastatic Breast Cancer" International Journal of Molecular Sciences 26, no. 5: 2038.
https://doi.org/10.3390/ijms26052038
APA Style
Szostakowska-Rodzos, M., Grzybowska, E. A., Mysliwy, I., Zub, R., Jagiello-Gruszfeld, A., Rubach, M., Konieczna, A., & Fabisiewicz, A.
(2025). The Combined Assessment of CTC and ESR1 Status in Liquid Biopsy Samples Enhances the Clinical Value of Prediction in Metastatic Breast Cancer. International Journal of Molecular Sciences, 26(5), 2038.
https://doi.org/10.3390/ijms26052038